Exp Biol Med (Maywood). 2006 Jan;231(1):39-49.

Mesenchymal stem cells and the treatment of cardiac disease.

Source

Laboratorio de Trasplante de Médula Osea, Clínica Las Condes, Lo Fontecilla 441, Las Condes, Santiago, Chile. jminguel@inta.cl

Abstract

The ischemia-induced death of cardiomyocytes results in scar formation and reduced contractility of the ventricle. Several preclinical and clinical studies have supported the notion that cell therapy may be used for cardiac regeneration. Most attempts for cardiomyoplasty have considered the bone marrow as the source of the "repair stem cell(s)," assuming that the hematopoietic stem cell can do the work. However, bone marrow is also the residence of other progenitor cells, including mesenchymal stem cells (MSCs). Since 1995 it has been known that under in vitro conditions, MSCs differentiate into cells exhibiting features of cardiomyocytes. This pioneer work was followed by many preclinical studies that revealed that ex vivo expanded, bone marrow-derived MSCs may represent another option for cardiac regeneration. In this work, we review evidence and new prospects that support the use of MSCs in cardiomyoplasty.

PMID:: 16380643; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Heart Diseases - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Mesenchymal stem cells and their potential as cardiac therapeutics. [Circ Res. 2004]
Review Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF, Martin BJ. Circ Res. 2004 Jul 9; 95(1):9-20.
Review Amniotic stem cells for cellular cardiomyoplasty: promises and premises. [Catheter Cardiovasc Interv. 2009]
Review Amniotic stem cells for cellular cardiomyoplasty: promises and premises.
Walther G, Gekas J, Bertrand OF. Catheter Cardiovasc Interv. 2009 Jun 1; 73(7):917-24.
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. [Vox Sang. 2008]
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, Watt SM. Vox Sang. 2008 Aug; 95(2):137-48. Epub 2008 Jun 28.
Review Myocardial regeneration with bone-marrow-derived stem cells. [Biol Cell. 2005]
Review Myocardial regeneration with bone-marrow-derived stem cells.
Yoon YS, Lee N, Scadova H. Biol Cell. 2005 Apr; 97(4):253-63.
Stem cell experiments and initial clinical trial of cellular cardiomyoplasty. [Asian Cardiovasc Thorac Ann. 2...]
Stem cell experiments and initial clinical trial of cellular cardiomyoplasty.
Guhathakurta S, Subramanyan UR, Balasundari R, Das CK, Madhusankar N, Cherian KM. Asian Cardiovasc Thorac Ann. 2009 Dec; 17(6):581-6.

See reviews... See all...

Cited by 4 PubMed Central articles

Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature. [Open Orthop J. 2011]
Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature.
P M, S H, R M, M G, W S K. Open Orthop J. 2011; 5(Suppl 2):253-60. Epub 2011 Jul 28.
Sources of adult mesenchymal stem cells applicable for musculoskeletal applications - a systematic review of the literature. [Open Orthop J. 2011]
Sources of adult mesenchymal stem cells applicable for musculoskeletal applications - a systematic review of the literature.
Mafi R, Hindocha S, Mafi P, Griffin M, Khan WS. Open Orthop J. 2011; 5 Suppl 2:242-8. Epub 2011 Jul 28.
Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. [J Transl Med. 2011]
Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs.
Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo AB, Padmanabhan J, Lee CN, de Kleijn DP, Lim SK. J Transl Med. 2011 Apr 25; 9:47. Epub 2011 Apr 25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Mesenchymal stem cells and the treatment of cardiac disease.
Mesenchymal stem cells and the treatment of cardiac disease.
Exp Biol Med (Maywood). 2006 Jan ;231(1):39-49.

PubMed
A mutation in myotilin causes spheroid body myopathy.
A mutation in myotilin causes spheroid body myopathy.
Neurology. 2005 Dec 27 ;65(12):1936-40.

PubMed
Sibling cardiovascular disease as a risk factor for cardiovascular disease in mi...
Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults.
JAMA. 2005 Dec 28 ;294(24):3117-23.

PubMed
Epidemiology and correlates of daily smoking and nicotine dependence among young...
Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States.
Am J Public Health. 2006 Feb ;96(2):299-308. Epub 2005 Dec 27 .

PubMed
Diarrheal illness detected through syndromic surveillance after a massive power ...
Diarrheal illness detected through syndromic surveillance after a massive power outage: New York City, August 2003.
Am J Public Health. 2006 Mar ;96(3):547-53. Epub 2005 Dec 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: